Humana Raises 2025 Adjusted EPS Outlook Amid Outperformance in CenterWell Pharmacy and Improved Medicare Advantage Retention

Humana (HUM) raised its 2025 adjusted EPS outlook to $17 from $16.25, driven by strong performance from CenterWell Pharmacy and improved Medicare Advantage (MA) member retention. The company also reported a smaller-than-expected decline in individual MA membership and in-line medical cost trends.

By Motley Fool Transcribing · Motley Fool · April 21, 2026, 15:58 UTC

Tickers: $HUM $UNH

Topics: CenterWell Pharmacy Earnings Guidance EPS Outlook Medicaid Expansion Medicare Advantage Share Repurchases

Read the full article at Motley Fool

More World news

Aline Accounting Partners Secures $206 Million in Financing Led by Square Nine Capital PR Newswire · November 12, 2026, 18:00 UTC
Egan-Jones November 2026 Report Shows Soft CLO Issuance Amid Improving Credit Metrics PR Newswire · November 12, 2026, 18:00 UTC
Blackbaud Reports Third Quarter Revenue Growth and Strategic AI Integration Motley Fool · November 12, 2026, 17:53 UTC
Sprott Physical Copper Trust Reports Significant Increase in Q3 Net Income Seeking Alpha · November 12, 2026, 17:51 UTC
Federal Reserve to Designate October 2027 Meeting as Non-Voting Strategic Session CNBC · November 12, 2026, 17:48 UTC
Sprott Physical Platinum and Palladium Trust Reports Q3 Net Income Decline Seeking Alpha · November 12, 2026, 17:47 UTC
Nvidia CEO Jensen Huang Resigns Amidst Market Volatility and AI Sector Shifts Motley Fool · November 12, 2026, 17:45 UTC
Honda to Transition CR-V Lineup to All-Hybrid Powertrains by 2027 Seeking Alpha · November 12, 2026, 17:43 UTC
Sprott Physical Silver Trust USD Reports Q3 Net Income of $425.83 Million Seeking Alpha · November 12, 2026, 17:44 UTC
Nvidia CEO Jensen Huang Resigns Amid Allegations of Personal Misconduct and China Export Control Concerns The Verge · November 12, 2026, 17:44 UTC